Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y

Danaher Corporation’s (DHR) second-quarter 2024 adjusted earnings (excluding 50 cents from non-recurring items) of $1.72 per share surpassed the Zacks Consensus Estimate of$1.57. The bottom line declined 0.6% year over year.Danaher’s net sales of $5.7 billion outperformed the consensus estimate of$5.6 billion. However, the metric declined 3% year over year due to lower core sales in the Biotechnology segment.Organic sales decreased 3.5%. Acquisitions had a positive impact of 2% on quarterly sales while ad ...